Arboretum Invests in Pathology Company

Arboretum Ventures, based in Ann Arbor, MI, is a co-leader in a $10-million Series B financing round for Irvine, Calif.-based PathCentral, an anatomic pathology services company, according to a report today in peHUB. PathCentral says the money will be used to enhance its web-based laboratory information system, among other things. Joining Arboretum in the round were Okapi Venture Capital and Baird Venture Partners.

Author: Howard Lovy

Howard Lovy is a veteran journalist who has focused primarily on technology, science and innovation during the past decade. In 2001, he helped launch Small Times Magazine, a nanotech publication based in Ann Arbor, MI, where he built the freelance team and worked closely with writers to set the tone and style for an emerging sector that had never before been covered from a business perspective. Lovy's work at Small Times, and on one of the first nanotechnology-themed blogs, helped him earn a reputation for making complex subjects understandable, interesting, and even entertaining for a broad audience. It also earned him the 2004 Prize in Communication from the Foresight Institute, a nanotech think tank. In his freelance work, Lovy covers nanotechnology in addition to technological innovation in Michigan with an emphasis on efforts to survive and retool in the state's post-automotive age. Lovy's work has appeared in many publications, including Wired News, Salon.com, the Wall Street Journal, The Detroit News, The Scientist, the Forbes/Wolfe Nanotech Report, Michigan Messenger, and the Ann Arbor Chronicle.